Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-068508
Date:2021-12-06
Issuer: CORBUS PHARMACEUTICALS HOLDINGS, INC. (CRBP)
Original Submission Date:

Reporting Person:

BRAKE RACHAEL LOUISE
500 RIVER RIDGE DRIVE
NORWOOD, MA 020162

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION(RIGHT TO BUY) 0.7474 2021-12-06 deemed execution date A 500,000 (a) 2031-12-06 common stock 500,000 $0.75 500,000 direct
Footnotes
IDfootnote
f1 the option award was made in accordance with the terms of the issuer's 2014 equity compensation plan. 25% of the option vests on december 6, 2022, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on january 6, 2023.
WhaleWisdom Logo

Elevate your investments